GTR 108566442
Tenders Are Invited For A Sebelipase Alfa (Genetical Recombinaion, 20Mg 10Ml/1Vial) 147 Vials, Nushinersen Sodium (12Mg1Vial) 2 Vials, Cetuximab Sarotalocan Sodium (Genetical Recombination, 250Mg 50Ml1Vial) 62 Vials, Polatuzumab Vedotin (Genetical Recombination, 140Mg1Vial) 19 Vials, Polatuzumab Vedoti...
ICB — International Competitive Bid
Closed
Asia
Tender Information
GTR Reference
108566442
Tendering Authority
Subscribe to view
Tender No
381457
Financer Name
Self-Funded
Work Title
Tenders Are Invited For A Sebelipase Alfa (Genetical Recombinaion, 20Mg 10Ml/1Vial) 147 Vials, Nushinersen Sodium (12Mg1Vial) 2 Vials, Cetuximab Sarotalocan Sodium (Genetical Recombination, 250Mg 50Ml1Vial) 62 Vials, Polatuzumab Vedotin (Genetical Recombination, 140Mg1Vial) 19 Vials, Polatuzumab Vedoti...
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Asia
Political Region
Asia-Pacific Economic Cooperation, APEC,G20,APAC (Asia Pacific)
Last Date of Bid Submission
03-04-2026
Closed
Work Detail
A Sebelipase Alfa (Genetical Recombinaion, 20Mg 10Ml/1Vial) 147 Vials, Nushinersen Sodium (12Mg1Vial) 2 Vials, Cetuximab Sarotalocan Sodium (Genetical Recombination, 250Mg 50Ml1Vial) 62 Vials, Polatuzumab Vedotin (Genetical Recombination, 140Mg1Vial) 19 Vials, Polatuzumab Vedoti...
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
8490d16c-a5ab-4c04-b609-aa4f39285e58.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.